Damora Therapeutics, Inc. vs ASML Holding NV
A head-to-head of Damora Therapeutics, Inc. (DMRA) and ASML Holding NV (ASMLF) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | DMRA | ASMLF |
|---|---|---|
| Market Cap | $1.46B | $541.44B |
| P/E (TTM) | — | 45.19 |
| Forward P/E | 0.00 | 40.16 |
| P/S | 0.00 | 16.07 |
| P/B | 0.13 | 22.55 |
| EV/EBITDA | 0.46 | 38.65 |
| Dividend Yield | — | 0.55% |
| Profit Margin | 0.00% | 30.86% |
| Gross Margin | — | 52.83% |
| Operating Margin | 0.00% | 34.60% |
| Revenue Growth (YoY) | 0.00% | +13.25% |
| FCF Yield | -0.46% | 1.65% |
| Debt / Equity | 0.01 | 12.99 |
| Current Ratio | 12.98 | 1.36 |
Share:
Compare Damora Therapeutics, Inc. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.